menu

CME: Primary Care’s Skin in the Game: Psoriasis Identification, Treatment, and Referral Decisions

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Primary Care’s Skin in the Game: Psoriasis Identification, Treatment, and Referral Decisions

Program Information
Recommended
Primary Care’s Skin in the Game: Psoriasis Identification, Treatment, and Referral Decisions
RestartResume
Primary care providers need to know how to recognize and manage mild-to-moderate psoriasis and when it is time to refer to a specialist.

Available credits: 0.75

Time to complete: 40 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Family physician, Dr. Paul Doghramji, and dermatologist, Dr. Abby Van Voorhees, discuss 3 cases of psoriasis commonly seen in the primary care office.  Learn how to identify psoriasis from other dermatologic conditions, how to choose an appropriate treatment and when referral to a specialist is recommended.

  • Learning Objectives

    Upon completion of the activity, participants should be able to:

    • Identify practical strategies for confirming diagnosis in a busy primary care clinical setting
    • Apply key aspects of available guidelines to inform treatment selection and patient evaluation
    • Evaluate available and emerging agents approved for psoriasis, their mechanisms, and efficacy and safety data
    • Recognize scenarios in which referral to a specialist for diagnostic or treatment purposes is recommended
  • Faculty

    Paul P. Doghramji, MD, FAAFP
    Medical Director of the Wellness Center
    Ursinus College
    Attending Physician
    Collegeville Family Practice
    Collegeville, PA

    Khamini Guillermo DNP, CRNP, MSN
    Family Nurse Practitioner
    Ursinus College Wellness Center
    Collegeville, PA

    Abby S. Van Voorhees, MD
    Chair and Professor of Dermatology
    Eastern Virginia Medical School
    Norfolk, VA

  • Method of Participation / How to Receive Credit

    1. There are no fees for participating in and receiving credit for this activity.

    2. Review the activity objectives and CME/CE information.

    3. Complete the CME/CE activity

    4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.

    5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.

    6. Credit documentation/reporting:

      • If you are requesting AMA PRA Category 1 Credits™, ANCC credits, AAFP credits, or a certificate of participation—your CME/CE certificate will be available for download.
      • Physicians are expected to self-report AAFP credit.
      • If you are requesting MOC credit, your MOC points will be submitted electronically to the ACCME, which will register data and notify certifying boards.
  • Accredited Provider

    This activity is provided by The France Foundation.

  • Target Audience

    The education is intended for general internists and family physicians involved in the diagnosis and management of patients with psoriasis.

  • Statement of Need

    The diagnosis of psoriasis is often delayed or missed, and low-level knowledge by non-specialists is recognized as a barrier.  Multiple data sources confirm PCP knowledge and practice gaps and inconsistencies surrounding the management of psoriasis.  At the PCP level, attention to even the most basic of therapies and adherence to them is crucial, as is knowing when a complex and/or refractory case may need to be referred to a dermatologist for systemic treatment.  Data show that PCPs, both under- and over-refer psoriasis cases to dermatologists.  It is crucial that PCPs understand factors that should warrant consideration of referral to dermatology.  

  • Accreditation and Credit Designation Statements

    ACCREDITATION STATEMENT  

    The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    CREDIT DESIGNATION

    Physicians
    The France Foundation designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Maintenance of Certification

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Nurses
    This continuing nursing education activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.

    AAFP
    This Enduring Material activity, Primary Care's Skin in the Game: Psoriasis Identification, Treatment and Referral Decisions, has been reviewed and is acceptable for up to 0.75 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 01/23/2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Disclosure Policy

    In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

    Activity Staff Disclosures
    The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

    Faculty Disclosures-Content Creators
    The faculty listed below report that they have no relevant financial relationships to disclose:

    • Paul Doghramji, MD, FAAFP
    • Khamini Guillermo, DPN, CRNP, MSN
    • Shira Johnson, MD

    The following faculty report that they have relevant financial relationships to disclose:

    • Abby Van Voorhees, MD serves as a consultant for DermTech, Lilly, Novartis, UCB and WebMD. She does contract research for Celgene and Lilly. 

    Faculty Disclosures-MOC Reviewers
    The faculty listed below report that they have no relevant financial relationships to disclose:

    • Theodore Bruno, MD, FACEHP
    • Daniel Federman, MD, FACP

    DISCLOSURE OF UNLABELED USE

    TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information. 

  • Commercial Support Acknowledgement

    This activity is supported by an educational grant from Novartis.

  • Disclaimer

    The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

    COPYRIGHT INFORMATION
    Copyright © 2019 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

    • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

    • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission. 

  • Privacy Policy

    The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

    The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

    Additional information regarding The France Foundation’s Privacy Policy can be viewed at http://www.francefoundation.com/privacy.

    CONTACT INFORMATION
    If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 7/19/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.